At the 2019 annual meeting of the Association for Research in Vision and Ophthalmology, researchers from Kellogg Eye Center revealed that combining a smartphone-mounted device that takes high-quality retinal pictures with AI software might offer a solution for better screening of diabetic retinopathy.
According to Paulus, also a vitreoretinal surgeon at Kellogg Eye Center, "the key is to bring portable, easy-to-administer, reliable retinal screening to primary care doctors' offices and health clinics".
Paulus was part of a Kellogg team that developed a device that turns a smartphone into a functioning retinal camera. The team used the latest generation of the smartphone-based platform called RetinaScope.
"This is the first time that AI used on a smartphone-based platform has been shown to be effective compared with the gold standard of clinical evaluation," said Paulus.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)